How SJS Affects the Eyes

Stevens-Johnson Syndrome and Your Eyes: A Patient Guide to SJS Ocular Involvement

Schedule Today

(609) 586-0849
(609) 586-0849 Book Appointment
Rectangle 24
Rectangle 25

How SJS Affects the Eyes

SJS is an immune-mediated hypersensitivity reaction, meaning the immune system mistakenly attacks the body's own tissues. The eyes are among the most commonly affected areas, and the damage can range from mild surface irritation to severe, vision-threatening scarring.

SJS is a severe reaction that typically starts with flu-like symptoms and quickly progresses to involve the skin and mucous membranes, the delicate moist tissues lining areas such as the mouth, genitals, and eyes. It is part of a disease spectrum that includes toxic epidermal necrolysis (TEN), a more extensive form of the same condition. The difference between SJS and TEN is based on how much of the body's surface area is affected.

Most cases are triggered by certain medications, though infections can sometimes be the cause. Identifying and stopping the trigger as early as possible is a critical first step in treatment.

During an SJS episode, the immune system attacks the cells that line the eye surface. This reaction causes the protective outer layers of the conjunctiva (the clear tissue covering the white of the eye) and cornea (the clear front surface of the eye) to break down and peel away, leaving raw and inflamed tissue exposed.

The damage can destroy the glands responsible for producing tears and the limbal stem cells that help the cornea repair itself. Without these structures functioning properly, the eye surface struggles to heal and becomes vulnerable to scarring and infection. Scar tissue can also form between the inner eyelid and the eyeball, a condition called symblepharon, which creates lasting complications.

Eye symptoms in SJS typically appear within the first few days of an episode, often alongside skin blistering and mouth sores. The acute phase, the period of active tissue breakdown, usually lasts one to three weeks. This window is critical because the severity of treatment during this phase directly influences long-term outcomes.

After the acute phase ends, healing begins but can take several months. Some complications, such as progressive scarring, may not become apparent until weeks or even years after the initial episode. This delayed development makes lifelong follow-up eye care essential for all SJS survivors.

The first days and weeks of SJS largely determine how much permanent eye damage will occur. Early involvement of an eye specialist can reduce scarring, preserve tear production, and protect vision. Delays in treatment often lead to complications that are far more difficult to manage later.

Our immediate priorities include keeping the eye surface moist, preventing the eyelids from adhering to the eyeball, and controlling inflammation. These steps, taken as early as possible, can make the difference between good visual recovery and permanent impairment.

Recognizing Eye Symptoms and Warning Signs

Recognizing Eye Symptoms and Warning Signs

Recognizing eye symptoms early is essential. Because SJS moves quickly, knowing what to look for and when to act can protect your vision. Some symptoms appear in the first days, while others develop weeks or months after the acute episode.

The earliest eye symptoms of SJS include redness, burning, and a gritty or sandy feeling in both eyes. Eyes may water excessively or produce thick discharge. Light sensitivity (photophobia) is common and can be severe enough to make it difficult to keep the eyes open in normal lighting.

  • Red, bloodshot eyes that worsen quickly
  • Burning or stinging sensations in both eyes
  • A feeling of sand or grit in the eyes
  • Excessive tearing or sticky discharge
  • Difficulty keeping the eyes open in light

As SJS progresses into its acute phase, the eye surface begins to break down visibly. White or yellowish membranes, called pseudomembranes, may form over the white part of the eye and inside the eyelids. The eyelid skin may blister, peel, or become crusted.

Vision can become blurry during this phase due to surface damage and inflammation. The eyelids may swell severely, making it hard to open the eyes. These symptoms require immediate medical attention and specialized eye care without delay.

Weeks to months after recovering from SJS, new eye problems may appear or existing symptoms may worsen. These late complications signal that scarring or ongoing inflammation is affecting eye health and need prompt evaluation.

  • Persistent dry, gritty eyes despite regular use of artificial tears
  • Gradual vision decline or increased blurriness
  • Eyelashes turning inward and rubbing against the eye surface (trichiasis)
  • Cloudy or hazy areas on the cornea
  • Difficulty opening the eyes fully
  • A scratchy, rough sensation from hardened eyelid tissue (eyelid margin keratinization)
  • Recurring painful episodes of surface breakdown (corneal erosions)
  • Persistent light sensitivity or eye pain not relieved by lubrication

If you develop eye symptoms while also experiencing a spreading skin rash, mouth sores, genital sores, or fever, this is a medical emergency. Go to an emergency department immediately. Do not wait to see if symptoms improve on their own, as the window for preventing permanent eye damage is very short.

Your medical team should involve an eye specialist right away, even if eye symptoms seem mild compared to other problems. Emergency eye care should begin as soon as SJS is suspected, not only after a diagnosis is confirmed.

Causes of SJS and Who Is at Risk

Causes of SJS and Who Is at Risk

Understanding what triggers SJS and which factors increase risk can help prevent future episodes and guide safe medical care going forward. Most cases are caused by medications, but other factors also play a role.

Certain medications are responsible for most cases of SJS. The risk is highest within the first two to eight weeks of starting a new drug, especially when doses are increased quickly. If you develop a rash or mouth sores while taking a new medication, seek urgent medical attention immediately and do not restart the suspected drug.

  • Sulfonamide antibiotics and related drug classes
  • Antiseizure medications such as lamotrigine and carbamazepine
  • Allopurinol, used to treat gout
  • Some nonsteroidal anti-inflammatory drugs (NSAIDs)
  • Certain antibiotics including penicillins and quinolones

While medications cause the majority of SJS cases, infections can also trigger the syndrome. Viral infections including herpes simplex, bacterial infections such as mycoplasma pneumonia, and HIV have all been associated with SJS. In some cases, no clear trigger can be identified despite a thorough investigation.

Knowing your personal trigger is critically important because repeat exposure can cause another SJS episode, often more severe than the first.

Anyone can develop SJS, but certain factors increase the likelihood. People with weakened immune systems, including those with HIV or autoimmune conditions such as lupus, are at higher risk. A previous episode of SJS also significantly raises the risk of recurrence if the same trigger is encountered again.

Women appear to develop SJS slightly more often than men. The condition can occur at any age but is somewhat more common in adults than in children. Taking multiple medications at the same time may also increase the risk.

Certain genetic markers make some individuals significantly more likely to develop SJS when exposed to particular medications. Genetic testing before starting high-risk medications may be recommended in specific situations, particularly for people of certain ethnic backgrounds.

  • HLA-B15:02 testing before carbamazepine or oxcarbazepine in many East and Southeast Asian ancestries
  • HLA-A31:01 testing in some populations before carbamazepine
  • HLA-B58:01 testing before allopurinol in several Asian and some non-Asian ancestries
  • HLA-B57:01 testing before abacavir

Genetic testing is used selectively and does not replace careful clinical monitoring. If a family member has experienced SJS, inform all your doctors before starting any new medication. While SJS itself is not an inherited condition, genetic susceptibility to certain drug reactions can run in families.

How We Diagnose Eye Involvement in SJS

A thorough eye evaluation is essential both during the acute phase and throughout long-term follow-up. Our diagnostic process helps us understand the extent of eye damage, plan treatment, and track your recovery over time.

When we examine your eyes during or after an SJS episode, we carefully assess every part of the eye surface, eyelids, and surrounding structures. We look for signs of membrane formation, tissue breakdown, and scarring. The examination includes checking your vision, eye pressure, and the health of the cornea and conjunctiva.

We also evaluate your tear production and tear quality, since SJS often damages the glands that keep the eyes moist. Using a specialized microscope called a slit lamp, we can see fine details of any damage and track how your eyes are healing over each visit.

Beyond the standard eye exam, we may perform additional tests to fully understand the extent of your eye involvement. Most of these tests are quick and cause little to no discomfort.

  • Tear film evaluation to measure the severity of dryness
  • Schirmer test or tear meniscus assessment to quantify tear production
  • Corneal staining with safe dyes to reveal areas of surface damage
  • Conjunctival impression cytology to assess the health of surface tissue
  • Photographic documentation to track your eye condition over time

We use standardized grading systems to classify how severely SJS has affected the eyes. These grades range from mild surface inflammation to severe scarring and corneal damage. The initial grade helps us determine how aggressive treatment needs to be during the acute phase and whether interventions such as amniotic membrane placement or symblepharon rings are needed.

Grading also provides a baseline to track your progress at each follow-up visit. If we see worsening, we can escalate care promptly. If the situation is improving, we can adjust treatments accordingly.

SJS affects multiple body systems, so eye care must be closely coordinated with your other treating physicians. During the acute phase, we work with dermatologists, hospitalists, and intensive care teams to ensure that treatments for your skin and overall condition do not interfere with protecting your eyes.

We document the medication or trigger responsible for your SJS clearly in your medical record and provide allergy documentation to help prevent accidental reexposure. We share regular updates on your eye status with your broader care team and stay informed about any systemic therapies that may affect the eye surface.

Treatment Options for SJS Eye Complications

Treatment Options for SJS Eye Complications

Treatment for SJS eye involvement must begin as early as possible and continues long after the acute phase has resolved. Our approach is tailored to your individual situation and evolves as your eyes heal or as new complications arise.

During the acute phase, protecting the eye surface is our highest priority. We use intensive lubrication with preservative-free artificial tears and ointments, often applied every hour or more frequently. Removing inflammatory pseudomembranes from the eye surface may be necessary to prevent them from causing permanent scarring.

We take active steps to prevent the eyelids from adhering to the eyeball, a complication called symblepharon. Standard acute-phase measures include the following:

  • Early placement of self-retaining amniotic membrane for moderate to severe eye surface involvement, ideally within the first three to seven days
  • Use of symblepharon rings or conformers to keep the inner eyelid surfaces separated
  • Daily gentle removal of pseudomembranes and sweeping of the fornices (the recesses between the eyelid and eyeball) to prevent adhesions
  • Use of preservative-free formulations only whenever possible
  • Avoidance of sulfonamide-containing topical antibiotics if a sulfonamide drug triggered the SJS episode

We may prescribe several types of eye drops and topical medications to control inflammation and support healing. The specific combination depends on the severity of your eye involvement and how your eyes respond over time.

  • Preservative-free artificial tears for intensive and frequent lubrication
  • Non-sulfa prophylactic antibiotic ointment to reduce infection risk in areas where the surface tissue has broken down
  • Topical corticosteroids, which may be used early under specialist supervision to control inflammation and reduce scarring risk, with dosing and tapering individualized to your needs

Autologous serum eye drops (drops made from your own blood components) or platelet-derived drops are typically considered during the subacute or chronic phase when the active episode has settled.

Amniotic membrane transplantation involves placing a thin layer of tissue derived from human placenta onto the eye surface. This biological bandage reduces inflammation, promotes healing, and may help prevent scarring. We may recommend this treatment during the acute phase for moderate to severe surface damage.

Self-retaining amniotic membrane devices can be placed at the bedside in hospitalized patients, making early treatment possible even without an operating room. The membrane dissolves gradually as your own tissue heals beneath it. Early use of amniotic membrane has been shown to improve long-term outcomes in severe SJS eye involvement.

Many SJS survivors develop chronic dry eye that persists for years or permanently. This condition requires a layered, individualized approach. We work with you over time to find the right combination of therapies for your specific situation.

  • Punctal occlusion or cautery to block the drainage channels and retain natural tears
  • Moisture chamber eyewear and home humidification to reduce tear evaporation
  • Scleral lenses, including PROSE devices, once the eye surface is stable and fitting is performed by specialists
  • Topical anti-inflammatory therapies such as cyclosporine or tacrolimus when appropriate
  • Autologous serum or platelet-rich plasma drops for severe ocular surface disease

If scarring causes complications such as inward-turning eyelashes (trichiasis), eyelid deformities, or scar tissue binding the eyelid to the eyeball, surgery may become necessary. These procedures aim to improve comfort and protect the cornea from ongoing damage.

  • Mucous membrane grafting to treat eyelid margin keratinization and restore a smooth lid surface
  • Fornix reconstruction with mucous membrane grafts to address symblepharon
  • Permanent punctal cautery for severe cases of inadequate tear production
  • Tarsorrhaphy, a procedure to partially close the eyelids, in cases of persistent corneal breakdown
  • Limbal stem cell-based ocular surface reconstruction in select cases; keratoprosthesis (artificial cornea) is considered when conventional transplantation is unlikely to succeed

For severe corneal scarring that causes vision loss, corneal transplantation may be considered in specific cases. However, eyes damaged by SJS have lower transplant success rates due to poor tear production and ongoing inflammation, so surgical planning is done carefully and individually.

Recovery and Long-Term Eye Care After SJS

Recovery and Long-Term Eye Care After SJS

Recovery from SJS eye involvement is a gradual process that unfolds over many months and requires ongoing attention for the rest of your life. The care you maintain after the acute phase is just as important as the initial treatment.

During the first few weeks after the acute phase, you will likely still experience significant redness, discomfort, and light sensitivity. These symptoms should slowly improve, though progress can feel frustratingly slow at times. Complete healing of the eye surface may take three to six months or longer, and some symptoms, particularly dryness, may never fully resolve.

We monitor your healing closely during this period to detect any complications early and adjust your treatment plan as needed. Open communication about any new or worsening symptoms is important throughout this phase.

Your daily eye care routine at home plays a crucial role in your long-term outcome. Using your prescribed drops and medications consistently, even when your eyes feel relatively comfortable, helps maintain the healing surface and prevent setbacks.

  • Apply preservative-free artificial tears at least four to six times daily, or as prescribed
  • Use thick lubricating ointment at bedtime to prevent overnight drying
  • Wear wraparound sunglasses outdoors to reduce light sensitivity and protect against wind and dust
  • Keep eyelids clean with warm compresses and gentle cleansing if directed by your eye doctor
  • Use a home humidifier and moisture chamber glasses to reduce tear evaporation
  • Avoid smoke, dust, and other environmental irritants that can worsen symptoms
  • Do not use over-the-counter redness relievers or topical anesthetic eye drops
  • Avoid rubbing your eyes
  • Do not wear contact lenses unless your eye doctor has specifically cleared you and provided guidance

We see patients frequently during the first few months after SJS. In the acute phase, visits may be weekly or more often. As your eyes stabilize, appointments are spaced gradually further apart. During the first year, visits at least every few months are typically necessary.

Even after achieving stable healing, we recommend eye exams at least once or twice yearly for life. These long-term visits allow us to detect late complications early and adjust your care plan to preserve the best possible vision and comfort. Contact us sooner if you experience worsening pain, increased light sensitivity, decreased vision, or new discharge between scheduled visits.

Protecting your vision after SJS requires lifelong commitment. Always carry a record of the medication or trigger responsible for your SJS episode and share it with every healthcare provider you see. Reexposure to the trigger can cause a second episode that is often even more damaging than the first.

Stay attentive to changes in your eye comfort and vision and report them promptly. Maintaining your daily eye care routine even during symptom-free periods helps preserve the gains made during treatment. With consistent, careful management, many SJS survivors maintain functional vision and a good quality of life.

Frequently Asked Questions

Frequently Asked Questions

These answers address common points of uncertainty that patients and families often have after an SJS diagnosis, including decisions about when to act and what to expect over time.

Yes, permanent vision loss is possible, particularly when eye care is delayed or the initial damage is severe. The degree of long-term impairment varies widely from person to person. Many patients who receive prompt acute-phase care and maintain consistent long-term follow-up retain functional vision, while others may develop significant impairment despite treatment. This variability underscores the importance of beginning eye care at the very first sign of SJS and continuing it indefinitely.

Specialized scleral lenses, including PROSE devices, may benefit some SJS survivors. These large-diameter rigid lenses vault over the damaged cornea and rest on the white of the eye, creating a fluid reservoir that bathes the surface throughout the day. They can improve both vision and comfort in eyes with severe dry eye and corneal irregularity. However, scleral lenses are only appropriate after the eye surface has stabilized, and fitting requires a specialist experienced in post-SJS management. Not every patient is a candidate, and the fitting process can take multiple appointments to optimize.

Yes, and a second episode often causes more severe damage than the first. The immune system can react even more aggressively upon reexposure to the same trigger. Strictly avoiding your documented trigger is the most important step you can take. We provide written documentation of your trigger for your medical records and encourage you to share this information with every prescribing clinician to prevent accidental reexposure.

You should see an eye specialist as soon as SJS is suspected, ideally within the first 24 to 48 hours of symptom onset. Waiting even a few days can allow pseudomembrane formation and early scarring to progress to a point where they are much harder to reverse. If you are already hospitalized for SJS, request an eye specialist consultation immediately, even if your eye symptoms seem minor in comparison to your other problems. Early evaluation gives us the best opportunity to intervene before irreversible damage occurs.

Topical corticosteroids can be beneficial during the acute phase when prescribed and monitored by an eye specialist. They help reduce inflammation and may lower the risk of scarring when used appropriately. However, they are not safe to start, adjust, or stop without specialist guidance, as improper use can worsen certain complications or mask warning signs. Your treatment plan, including dosing and tapering, will be tailored to your individual eye findings and response to therapy.

If you develop a new rash while taking a recently started medication, seek urgent medical care immediately rather than waiting to see if it resolves. If that rash is accompanied by mouth sores, genital sores, eye symptoms, or fever, go to an emergency department right away. In suspected SJS, the triggering drug is stopped promptly under medical supervision. Never restart a suspected medication without clearance from your medical team, as doing so can provoke a severe reaction.

Expert Eye Care for SJS Patients

Expert Eye Care for SJS Patients

Stevens-Johnson Syndrome is a serious condition, and the eye complications it causes require experienced, dedicated care from diagnosis through lifelong follow-up. Our team is committed to working alongside your broader medical providers to protect your vision and support your quality of life at every stage of your recovery. We encourage anyone who has experienced SJS, or who suspects they may be developing it, to reach out to our practice so we can provide a thorough evaluation and a personalized plan of care.